Acacia Subsidiary Acquires Rights to Patent for Intralum
January 25, 2010 06:02 AM Eastern Time
NEWPORT BEACH, Calif.--(EON: Enhanced Online News)--Acacia Research Corporation (Nasdaq:ACTG) announced today t
has acquired the rights to a patent for intraluminal device technology.
"As Acacia's licensing success grows, more patent owners are selecting us as their partner for the licensing of their patented technol
Paul Ryan, Acacia Chairman and CEO. "Acacia is rapidly becoming the leader in technology licensing and we continue to grow our
revenues by adding new patent portfolios," concluded Mr. Ryan.
This patented technology generally relates to securing intraluminal devices, such as stent grafts, in the body.
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research’s subsidiaries develop, acquire, and license patented technologies. Acacia Research’s subsidiaries control over 14
portfolios, covering technologies used in a wide variety of industries.
Information about Acacia Research is available at www.acaciatechnologies.com and www.acaciaresearch.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private S
Litigation Reform Act of 1995.These statements are based upon our current expectations and speak only as of the date her
become the licensing partner for companies, and our actual results may differ materially and adversely from those express
forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affect
companies, theability to successfully develop licensing programs and attract new business, rapid technological change in re
changes in demand for current and future intellectual property rights, legislative, regulatory and competitive developments
licensing and enforcement of patents and/or intellectual property in general, and general economic conditions.Our Annual